We work at the convergence of science, medicine, and engineering to reinvent the process of drug discovery and treatment.

The Harvard Program in Therapeutic Science (HiTS) is an academic research and education program that advances the fundamental science underlying human diseases and drug discovery in order to improve patient care.


Our faculty, trainees, and staff study disease using innovative approaches that fuse laboratory investigation, clinical research, and computer science to accelerate the invention of the life-saving medicines and precision diagnostics that are needed to optimally treat individual patients.


HiTS brings together two approaches:

The Laboratory of Systems Pharmacology makes it possible to study the changes that promote disease and the ways in which therapeutic drugs function at the molecular level.

The Center for Regulatory Science focuses on evaluating drugs in clinical trials and balancing the benefits and risks of new medicines.

News, Events, & Updates

From Data to Discovery Seminar Series

“Managing Data by Managing Metadata”

Stuart Levine, Ph.D. | Director of BioMicro Center, Massachusetts Institute of Technology

February 14, 1-2pm ET | Goldenson 122

Watch Previous Data to Discovery Seminars

HiTS Social Lunch

“NIH Data Management Plans”

Sarah Arena and Allison Maier

December 6, 12-1:30pm | ARM108

Regulatory Science Forum

“The Impact on Risk Evaluation and Mitigation Strategies (REMS) on Clinical Practice and Generic Drug Availability”

Dr. Ameet Sarpatwari, Assistant Director at the Program On Regulation, Therapeutics, and Law (PORTAL)

November 7, 12:00pm ET

Register here!